Top Markets
#1 Siacoin Siacoin +16.51%
#2 Seeker Seeker +13.30%
#3 Cash Cat Cash Cat +12.44%
#4 DogBull DogBull +9.95%
#5 0G 0G +9.07%
#6 Useless Coin Useless Coin +5.74%
#7 StonkBroker StonkBroker +4.63%
#8 The Black Bull The Black Bull +4.56%
#9 Akedo Akedo +4.31%
#10 Story Story +4.27%
Coin of the day
Siacoin Siacoin
설정
언어
한국어
통화
USD
테마
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
주식 순위 #14209
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
주가
$12.33
마지막 동기화: 2026-08-31
시가총액
$428.31M
변동 (1일)
0.49%
변동 (1년)
39.01%
국가
US
거래 Fennec Pharmaceuticals Inc. (FENC)

카테고리

Healthcare
Fennec Pharmaceuticals Inc. (FENC)의 EPS
2026 기준 EPS TTM: 0
Fennec Pharmaceuticals Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Fennec Pharmaceuticals Inc.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH